南昌大学学报(医学版)
南昌大學學報(醫學版)
남창대학학보(의학판)
ACTA ACADEMIAE MEDICINAE JIANGXI
2014年
1期
7-9
,共3页
肖卫东%刘智文%文武%王福飞%廖国良%李勇
肖衛東%劉智文%文武%王福飛%廖國良%李勇
초위동%류지문%문무%왕복비%료국량%리용
miR-148a/b%真核表达质粒%胰腺癌
miR-148a/b%真覈錶達質粒%胰腺癌
miR-148a/b%진핵표체질립%이선암
miR-148a/b%eukaryotic expression vector%pancreatic cancer
目的:构建miR-148a/b真核表达质粒,转染胰腺癌AsPC-1细胞,并观察其miR-148a/b的表达水平。方法根据miRBase提供的序列合成miR-148a/b前体,PCR扩增后形成双链,插入线性化真核表达质粒pcDNA3.1,构建pcDNA3.1/miR-148a/b,进行酶切和测序鉴定。将胰腺癌 AsPC-1细胞分4组进行质粒转染:转染 pcDNA3.1/miR-148a(miR-148a组)、转染 pcDNA3.1/miR-148b(miR-148b组)、转染 pcDNA3.1(空质粒对照组)和仅加脂质体(空白对照组)。转染48 h后,采用定量 PCR法检测各组细胞中 miR-148a/b 的表达量。结果 pcDNA3.1/miR-148a/b的酶切和测序与miRBase提供的序列完全一致。转染48 h后,miR-148a组 AsPC-1细胞中的 miR-148a表达量明显高于空质粒对照组和空白对照组(6.76±0.35比1.00±0.54、1.02±0.40,均P<0.05),miR-148b 组AsPC-1细胞中的miR-148b表达量明显高于空质粒对照组和空白对照组(3.28±0.08比1.02±0.35、1.01±0.28,均P<0.05)。结论成功构建了 miR-148a/b真核表达质粒 pcDNA3.1/miR-148a/b,该质粒能显著上调胰腺癌 AsPC-1细胞的miR-148a/b表达水平。
目的:構建miR-148a/b真覈錶達質粒,轉染胰腺癌AsPC-1細胞,併觀察其miR-148a/b的錶達水平。方法根據miRBase提供的序列閤成miR-148a/b前體,PCR擴增後形成雙鏈,插入線性化真覈錶達質粒pcDNA3.1,構建pcDNA3.1/miR-148a/b,進行酶切和測序鑒定。將胰腺癌 AsPC-1細胞分4組進行質粒轉染:轉染 pcDNA3.1/miR-148a(miR-148a組)、轉染 pcDNA3.1/miR-148b(miR-148b組)、轉染 pcDNA3.1(空質粒對照組)和僅加脂質體(空白對照組)。轉染48 h後,採用定量 PCR法檢測各組細胞中 miR-148a/b 的錶達量。結果 pcDNA3.1/miR-148a/b的酶切和測序與miRBase提供的序列完全一緻。轉染48 h後,miR-148a組 AsPC-1細胞中的 miR-148a錶達量明顯高于空質粒對照組和空白對照組(6.76±0.35比1.00±0.54、1.02±0.40,均P<0.05),miR-148b 組AsPC-1細胞中的miR-148b錶達量明顯高于空質粒對照組和空白對照組(3.28±0.08比1.02±0.35、1.01±0.28,均P<0.05)。結論成功構建瞭 miR-148a/b真覈錶達質粒 pcDNA3.1/miR-148a/b,該質粒能顯著上調胰腺癌 AsPC-1細胞的miR-148a/b錶達水平。
목적:구건miR-148a/b진핵표체질립,전염이선암AsPC-1세포,병관찰기miR-148a/b적표체수평。방법근거miRBase제공적서렬합성miR-148a/b전체,PCR확증후형성쌍련,삽입선성화진핵표체질립pcDNA3.1,구건pcDNA3.1/miR-148a/b,진행매절화측서감정。장이선암 AsPC-1세포분4조진행질립전염:전염 pcDNA3.1/miR-148a(miR-148a조)、전염 pcDNA3.1/miR-148b(miR-148b조)、전염 pcDNA3.1(공질립대조조)화부가지질체(공백대조조)。전염48 h후,채용정량 PCR법검측각조세포중 miR-148a/b 적표체량。결과 pcDNA3.1/miR-148a/b적매절화측서여miRBase제공적서렬완전일치。전염48 h후,miR-148a조 AsPC-1세포중적 miR-148a표체량명현고우공질립대조조화공백대조조(6.76±0.35비1.00±0.54、1.02±0.40,균P<0.05),miR-148b 조AsPC-1세포중적miR-148b표체량명현고우공질립대조조화공백대조조(3.28±0.08비1.02±0.35、1.01±0.28,균P<0.05)。결론성공구건료 miR-148a/b진핵표체질립 pcDNA3.1/miR-148a/b,해질립능현저상조이선암 AsPC-1세포적miR-148a/b표체수평。
Objective To construct miR-148a/b eukaryotic expression vector,and to explore its expression in pancreatic cancer AsPC-1 cells.Methods The pri-miR-148a/b was synthesized ac-cording to the miRBase and double-stranded oligonucleotides were generated by PCR.The miR-148a/b were cloned into pcDNA3.1 vector and identified by enzyme digestion and sequence analy-sis.AsPC-1 cells were divided into four groups:pcDNA3.1/miR-148a transfection group(miR-148a group),pcDNA3.1/miR-148b transfection group(miR-148b group),pcDNA3.1 transfection group(empty vector control group),lipofectamine transfection group(blank control group).The expression of miR-148a/b was detected by real-time quantitative PCR at 48 hours after transfec-tion.Results The pcDNA3.1/miR-148a/b identified by enzyme digestion and sequence analysis was completely consistent with the sequence from miRBase database.After of transfection 48 hours,the AsPC-1 cells expression of miR-148a in miR-148a group(6.76±0.35)was significantly higher than that in empty vector control group(1.00±0.54)and blank control group(1.02± 0.40)(P<0.05).In addition,the expression of miR-148b in miR-148b group(3.28±0.08)was significantly higher than in empty vector control group(1.02±0.35)and blank control group(1. 01±0.28)(P<0.05).Conclusion The miR-148a/b eukaryotic expression vector has been suc-cessfully constructed.The pcDNA3.1/miR-148a/b can significantly increase the expression of miR-148a/b in pancreatic cancer AsPC-1 cells.